Marketing Of Pharmaceutical Products Research Articles

Microbiological Quality of Selected Non-Sterile Pharmaceutical Products Retailed in Anyigba, Kogi State, Nigeria

This study was designed to check for the microbiological quality of non-sterile products retailed in Anyigba. The use of contaminated non-sterile pharmaceutical products can cause hazards in a majority of ways like economic loss to the industrialists, alter the therapeutic effect of the drug and affect the health of a patient. A total of 10 samples were collected; the isolated organisms were characterized and identified by using morphological, cultural and biochemical tests. The organisms isolated were Staphylococcus aureus, E.coli and Pseudomonas spp, Aspergillus spp, Mucorspp, Saccharomyces spp and Rhizopus spp. The percentage of the isolate includes S. aureus 37 (45.7%), E.coli 16 (19.7%) Pseudomonas spp 28 (34.5%) to safeguard the product from contamination, it is important to ensure that good manufacturing practices such as raw material testing, equipment sanitization and automation, microbial testing of water, training of personnel, post marking surveillance, monitoring of environment among others were employed. The focus should also be on surveillance and effective monitoring of the distribution and marketing of pharmaceutical products. Local regulatory agencies such as the Standard Organization of Nigeria (SON), and the National Agency for Food,drug administration and Control (NAFDAC) should always ensure that all pharmaceuticals released into the market for sales and consumption should conform to specifications and are fit for their intended use.

Microbiological Quality of Selected Non-Sterile Pharmaceutical Products Retailed in Anyigba, Kogi State, Nigeria

This study was designed to check for the microbiological quality of non-sterile products retailed in Anyigba. The use of contaminated non-sterile pharmaceutical products can cause hazards in a majority of ways like economic loss to the industrialists, alter the therapeutic effect of the drug and affect the health of a patient. A total of 10 samples were collected; the isolated organisms were characterized and identified by using morphological, cultural and biochemical tests. The organisms isolated were Staphylococcus aureus, E.coli and Pseudomonas spp, Aspergillus spp, Mucorspp, Saccharomyces spp and Rhizopus spp. The percentage of the isolate includes S. aureus 37 (45.7%), E.coli 16 (19.7%) Pseudomonas spp 28 (34.5%) to safeguard the product from contamination, it is important to ensure that good manufacturing practices such as raw material testing, equipment sanitization and automation, microbial testing of water, training of personnel, post marking surveillance, monitoring of environment among others were employed. The focus should also be on surveillance and effective monitoring of the distribution and marketing of pharmaceutical products. Local regulatory agencies such as the Standard Organization of Nigeria (SON), and the National Agency for Food,drug administration and Control (NAFDAC) should always ensure that all pharmaceuticals released into the market for sales and consumption should conform to specifications and are fit for their intended use.

The Extent to Which the Strategic Spectrum is Employed in the Marketing of pharmaceutical products, an exploratory study in a number of drug stores and medical supplies in the city of Mosul

The objective of the research was to determine the extent to which the strategic spectrum is employed in the pharmaceutical industries marketing outlets. The warehouses of medicines and medical supplies operating in the city of Mosul were a research field through which data were collected and obtained from the research sample, who numbered (33) individuals working in the researched drug stores. The questionnaire was then used as a main tool for collecting the required data from the research sample, and based on a set of statistical methods, the data were analyzed and hypotheses tested, using the statistical software (SPSS). The competition taking place among them, and the research presented a set of proposals, the first of which is the necessity of making the strategic spectrum an entry point and an approach in diversifying business models that the researched assets can adopt in their quest to develop their position in the market.
 

Turkey – Certain Measures Concerning the Production, Importation and Marketing of Pharmaceutical Products, WT/DS583/ARB25.

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Quality Control and Quality Assurance in Pharmaceutical Industry

Quality assurance can be defined as “the part of quality management aimed at ensuring confidence that quality must be performed”. The trust provided by quality assurance is dual internal to management and external to clients, government agencies, regulators, certification bodies and third parties. An alternative definition is “the complete performance of targeted and organized activities within the framework of a quality method that can be documented to provide assurance that the commodity or service will meet the required quality. Quality assurance is comprehensive and does not have to do with the specific necessity of the product being developed. Quality Assurance (QA), Quality Control (QC), and Good Manufacturing Practice (GMP) are major considerations in the manufacturing, distribution, and marketing of pharmaceutical products to ensure their identification, potency, purity, pharmacological safety, and efficacy and effectiveness. (8) The terms Quality Assurance, Quality Control and Good Manufacturing Practices are defined in most international regulatory documents including WHO, USFDA, MHRA,TGA, MCC, etc. The quality of a pharmaceutical manufacturer's products depends on the fact that up to what satisfactory level of QA, QC and GMP system has been adopted in the process of production, distribution and marketing of products during their total shelf life. The main objective of this article is to demonstrate the fundamental difference between quality assurance, quality control and good manufacturing practice (GMP) and to emphasize their necessity for a pharmaceutical product. (8) This overview describes quality by design and identifies some of its elements. Process parameters and quality attributes are identified for every unit operation. The advantages, opportunities and steps involved in Quality by Design for pharmaceutical products are described. It is based on ICH guidelines Q8 for pharmaceutical development, Q9 for quality risk management and Q10 for pharmaceutical quality systems. It also provides the application of Quality by Design in pharmaceutical drug development and manufacturing.

Influence of pharmaceutical representatives on prescription decisions by physicians in Qassim province.

Pharmaceutical representatives are an important part of the marketing of pharmaceutical products and an important source of prescribing information for common practitioners. Thus, this study aims to identify factors that affect physicians' drug selection decisions, determine the main source of information for physicians about new drugs, and the most effective reminder methods used by pharmaceutical representatives. This study is a cross-sectional study that was distributed to doctors in different health specialties and different clinics and hospitals in the Qassim region from February to March 2020. The data collected were analyzed using Microsoft Excel. The Internet is the most considered main source of new drug information. Moreover, hospital policy is the most common factor that affects physicians' drug selection decisions. Finally, leaflets and pharmaceutical sales representatives' (PRs') frequent visits are the most effective reminder methods. This study showed the main source of new drug information was the Internet. In comparison, the factor that affects the physician's drug selection decision in this study was hospital policy. Finally, the most effective reminder methods were PRs' frequent visits and also an equal percentage leaflet.

Evaluation logistics processes efficiency of cold supply hain in the chinese pharmaceutical products market

Evaluation logistics processes efficiency of cold supply hain in the chinese pharmaceutical products market

How choosing the right transfection reagent can drastically bring down costs of AAV manufacturing

<h3>Watch the video or read the poster to learn:</h3> <ul><li>How to choose the right transfection reagent</li><li>Impact of transfection performance on viral vector manufacturing costs and costs per dose</li><li>How novel technology can reduce AAV manufacturing costs</li></ul><div class="authors authors-lg"><div class="author"><div class="author-img"><img src="https://bioinsights.blob.core.windows.net/uploads/Dumont headshot copy.png" data-image="1"></div><div class="author-det"> <b>Maxime Dumont</b> is a cell and gene therapy product manager at Polyplus-transfection®. With two master’s degrees in biochemistry, project management and marketing of pharmaceutical products, Maxime is managing the CGT transfection reagent portfolio for over 4 years. </div></div></div>

A Study on Marketing of Pharmaceutical Products based on Physicians and Consumers Behaviour

A Study on Marketing of Pharmaceutical Products based on Physicians and Consumers Behaviour

Comparative Analysis of Approaches to Assess the Quality of Inactivated Influenza Vaccines: Regulatory Requirements in the Russian Federation and European Union

The experience with the influenza pandemic caused by strain A (H1N1) 2009 and the existing gaps in standardizing and evaluating the quality and effectiveness of vaccines for influenza prevention have led the European Union (EU) to recognize the need to review / update the current guidelines on requirements for the development, quality, and preclinical and clinical research. In February 2018 Guideline on influenza vaccines -quality module (EMA/CHMP/BWP/310834/2012 Rev.l) came Into effect In the EU countries. The formation of the Eurasian Economic Union (EAEU) and the creation of a single market for pharmaceutical products entails the need to amend the current and the formation of new legislation, as well as changes in the rules and regulations regarding the pharmaceutical circulation processes in the Russian Federation: development, quality assurance in preclinical and clinical trials, monitoring the safety of medicines for medical use, in this regard, it seems appropriate to develop scientific and technical guidelines that are harmonized with international standards and approaches in the pharmaceutical field. The aim of the review was to conduct a comparative analysis of approaches to assessing the quality of vaccines for prevention influenza based regulatory requirements in the Russian Federation and European Union. Conclusion. In this article discusses the features of the requirements for the development and quality control of inactivated influenza vaccines in the Russian Federation and the EU. The article provides a comparative analysis of the requirements of the State Pharmacopoeia of the Russian Federation and the European Pharmacopoeia for quality indicators, which should be included in the regulatory documentation when registering the vaccine. The main changes in the EMA document «Guidelines for influenza vaccines - Quality module» consist of new approaches to standardizing vaccines for influenza prevention, in particular, determining the specific activity of inactivated influenza vaccines using adequate alternative methods and studying biological, immunological and physicochemical characteristics HA antigen using a wide range method. The results of the analysis of approaches to assessing the quality of vaccines for influenza prevention can be useful in developing harmonized with international norms and approaches scientific and technical guidelines in the pharmaceutical field.

The role of human resources management practices in enhancing the level of social responsibility (An exploratory study of the opinions of a sample of workers in the company Hawkari pharmaceuticals and medical supplies in Iraq)

This study aims to identify the role of of human resource management practices and the level of social responsibility in the Iraqi Hawkary company which is engaged in the distribution and marketing of pharmaceutical products, along with to identify the role of (correlation and impact) of the practices of human resources management in enhancing the level of social responsibility. Directed by the built model, two main hypotheses and drives from them sub hypotheses rises, a questionnaire used as a tool to collect data, amd to test hypotheses of study, the researchers relying on a set of statistical methods. 60 questionnaires distributed to the study samle, 51 questionnaires returned, while 44 questionnaires were suitable for analysis. The most result of this study was the following: the level of human resource management practices and social responsibility in Hawkary Company is high. There is a positive correlation between practices of human resource management and enhance the level of social responsibility in Hawkary pharmaceutical company. There is stastically a significant impact of human resource management practices on enhances the level of social responsibility in Hawkary pharmaceutical company. Based on the this results this study recommend to the need for the companies to rely on diverse sources of attraction and selection of professionals, companies should working tokeep excellence human resources and the application of occupational safety measures and develop specific programs to reduce accidents at work and the need for the Department companies activating style human relationships at work and that treats all employees of the company fair and equal manner. Keywords: Human resource management practices, social responsibility, economic responsibility, legal responsibility and ethical responsibility.

A Study of Marketing Strategies of Pharmaceutical Industry in India

Indian pharmaceutical industry is growing with leaps and bound. The growth in Indian pharmaceutical companies is not only in terms of market capitalization but its affordability and availability is also appreciable. Modern day’s pharmaceutical businesses are very complex. Earlier the businesses were using easy marketing tactics to meet the needs of market. Medical products could easily build their brand status. Building brand trust, attracting purchase, creating brand affect and brand loyalty was easier. Marketing and branding revolve around media, message repetitions, recall value and creativity. &#x0D; In present study the Indian pharmaceuticals companies’ branding techniques have been studied. It is never possible to observe the impact in general and about all the branding techniques used by companies. The study is based on a survey of 500 respondents. We have taken four hypotheses related to the issue. For the testing of hypothesis correlation (r) and multiple correlation coefficient(R) is calculated. Further we have mentioned the other findings that we came across while study that can contribute to the marketing of pharmaceutical products.

SERVIER V COMMISSION: FOLLOWING IN THE FOOTSTEPS OF LUNDBECK

To download this paper please click https://discovery.ucl.ac.uk/id/eprint/10086919In 2009, the European Commission’s Competition Inquiry into the Pharmaceutical Sector focused on the competitive relationship between originator companies and generic undertakings. The Commission discovered that patent settlement agreements containing a reverse transfer of value from the originator to the generic undertaking were used to delay entry of generics into markets, limit consumers’ choices, and burden public budgets. Since the Inquiry, the Commission adopted a more aggressive enforcement approach towards these patent settlements. In the recent Servier decision, it determined that the relevant agreements were in breach of Articles 101 and 102 TFEU. This commentary assesses the merits of Lundbeck’s general rule on reverse payment settlements, evaluates the General Court’s review of that decision in Servier and the exemption created for licensing agreements, and illustrates the difficulties in defining the relevant market for pharmaceutical products.

The Structure of the World Pharmaceutical Market: Prioritizing Iran's Target Export Markets.

Iran`s pharmaceutical products market has faced fluctuations over time. Suitable market selection is necessary for stability of pharmaceutical exports. This study aimed to determine the structure of the world pharmaceutical market and to identify the target of Iranian pharmaceutical export. T do so, concentration ratios and Herfindahl index were used to address the world pharmaceutical market from 2001 to 2012. Also, a composite index was used to identify the target markets of Iran's pharmaceutical industry. The results showed that the export side of world pharmaceutical trade has shifted to open oligopoly, thereby decreasing the monopolistic power of exporters. The import side, however, follows monopolistic competition. It has been observed that the structure of Iran's pharmaceutical export is shifting to open oligopoly; though, pharmaceutical importers from Iran have not been stable. Moreover, 27 countries were identified as target markets. Due to significant differences between the current and potential export destinations of Iran's pharmaceutical products, exporters should choose suitable strategies in order to diversify export markets. Such mechanisms as setting preferential tariffs on the basis of bilateral agreements, following effective advertisment, and paying attention to global consumers'preferences can be used to develop Iran's pharmaceutical export to target countries.

Medicinal products market and financial position of pharmaceutical companies in the Republic of Croatia

The healthcare needs are unpredictable and inconsistent, and quite often their cost grows faster than the cost of living and real wages. The average life expectancy is set to increase by development and improvement of the standard of living, which automatically calls for higher expenses for financing of healthcare services. The continuous research and innovation in the segments of healthcare and pharmacy, as well as the increase in the number of expensive innovative medicinal products cause growth of prices of medicinal products sold by retail. The main aim of this paper is to analyse the pharmaceutical products market (level and structure of consumption) in Croatia and to assess the financial position of the main suppliers of medicinal products and the largest market participants – pharmaceutical companies.

Diseño de un plan estratégico para un laboratorio orientado a la revitalización organizacional

Con los constantes avances tecnológicos, mercados cambiantes, nuevos canales de distribución y de comunicación, las empresas hoy en día necesitan herramientas que les permitan marcar una diferencia con respecto a las demás, obligándose a generar estrategias eficaces que sirvan de base para alcanzar los objetivos empresariales. Esto sucede con Laboratorios S.A.S; es una empresa con un largo recorrido en la fabricación y comercialización de productos farmacéuticos, pero que hoy en día, por distintos factores como la falta de innovación, de metodologías y procedimientos adecuados, gestión de mercadeo y entre otros factores, se encuentra en una etapa de declive, en dónde sino toma las medidas necesarias para atacar la problemática, se podría desmoronar definitivamente la organización. Es por esto que se propuso un diseño de plan estratégico, que permita encaminar a la empresa a la revitalización organizacional deseada según las necesidades del entorno. Por eso se utilizaron herramientas de diagnóstico, análisis, prospectivas y propuestas de modelo de seguimiento, que le permitirán a la organización responder a los retos generados por la industria colombiana, que le permitirán así mismo entrar con fuerza al mercado y seguidamente aumentar sus ingresos.

Modeling the advertising strategy of enterprises on the pharmaceutical products market

An analysis of the studies results on the advertising strategies formation for industrial enterprises is carried out. The specifics of the advertising strategies development by pharmaceutical industry enterprises are determined. A review of well-known applications of the mathematical apparatus during the problem solution is explored. The necessity of using the simulation approach in the process of modeling advertising strategies is substantiated. Applied aspects of the use of simulation modeling are presented on the example model of the pharmaceutical enterprise advertising company. The model is implemented on the platform of the system of multi-threaded simulation AnyLogic. The expediency of using the proposed mathematical apparatus in increasing the efficiency of enterprises marketing activities is confirmed by the submitted results of simulation experiments.

Strategy to promote research and innovation in the pharmaceutical sector through interdisciplinary education

Health products and services innovation have a strong economic and social impact, particularly by a BRICS member such as Brazil, considered the 6th largest consumer market for pharmaceutical products. Among the many national strategies to address the vulnerability of the country in this aspect, it is the training of the pharmacist one of the key players in the innovation process. In 2017 Generalist Pharmacy Curriculum Guide was published, which includes innovation, entrepreneurship and interdisciplinarity for the first time as components of the Brazilian pharmacist training. The present study analyzed 3742 disciplines currently offered by 42 universities, taking as a parameter the requirements induced by the new curriculum guideline. The method used was the content analysis, supported by NVivo® software, which generated 113 categories of disciplines, distributed in 8 core areas and 9 areas of knowledge. The result showed there is insufficiency related to health care and health management core areas as well as hours of internship, while there is predominance of health technology (&gt; 75%) with only 2% of innovation besides inexpressive presence of entrepreneurship and interdisciplinarity. The study demonstrates that paradigmatic and substantial changes must be made by Universities in order to comply with the new Curriculum Guide and proposes strategic solutions to promote innovation from an interdisciplinary perspective.

A critique of medicalisation: three instances

ABSTRACTBy briefly exploring three different examples where the existence of mental illness and developmental delay has been presumed, this paper sheds light on the way what Foucault calls the emergence of a regime of truth, i.e. where something that does not exist is made to exist through the construction of a system of truth around it. The first example concerns the direct marketing of pharmaceutical products to consumers in the US, the second the use of psychology in semi-post-Cold War Korea, and the third the persisting authority of psychology in the treatment of the developmentally delayed. While these instances are not innately connected, looking at these as part of the process by which the authoritative knowledge is established will help us understand, albeit partially, the mechanism by which mental illness penetrates our lives as truth, and how this regime of truth is supported by the authority of psychology, psychiatry and psychoanalysis, what Foucault calls the ‘psy-function,’ reinforcing the medicalisation of our lives.

القيادة الادارية في تعزيز مستوى الولاء التنظيمي - دراسة تحليلية لآراء عينة من الأفراد العاملين في شركة هاوكاري لتجارة الادوية والمستلزمات الطبية في أربيل

The research seeks to identify the impact of administrative leadership on the level of organizational loyalty from the point of view of the personnel working in Hawkari Company, which consist in the field of distribution and marketing of pharmaceutical products in the Kurdistan region-Iraq. This study was carried out based on the descriptive analytical method by using the questionnaire as a tool to collect data from (40) individuals working in the company, and in order to analyze the data a set of statistical methods have been used to this purpose. The research found that there are good levels of administrative leadership and organizational loyalty in Hawkari Company, as well as a significant correlation between administrative leadership and organizational loyalty. Also, there is a statistically significant effect of the types of administrative leadership in the level of organizational loyalty. The most important recommendations are the need to strengthen the identity of the organization and its values in the personnel working by the managers who lead the company, as well as the need to provide incentives for employees in such a way that prevent the turnover.